Infinity Pharmaceuticals | INFI - Gross Profit On Sales


Infinity Pharmaceuticals reported $231K in Gross Profit on Sales for its fiscal quarter ending in June of 2023.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Amgen USD 6.48B 307M Sep/2025
AstraZeneca USD 12.39B 5M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Cipla INR 41.64B 6.31B Dec/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 241K 649K Sep/2025
CSL USD 1.75B 2.53B Jun/2025
Eisai JPY 168.85B 17.02B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Grifols EUR 766.49M 39.74M Dec/2024
Incyte USD 1.39B 118.68M Dec/2025
Infinity Pharmaceuticals USD 231K 59K Jun/2023
Ionis Pharmaceuticals USD 155M 293M Sep/2025
J&J USD 16.6B 118M Dec/2025
Novartis USD 10.82B 695M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
TG Therapeutics USD 133.62M 11.41M Sep/2025